mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
2e-05 |
mRNA |
RO-3306 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0002 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0003 |
mRNA |
bid1870 |
gCSI |
pan-cancer |
AAC |
0.21 |
0.0004 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.002 |
mRNA |
LFM-A13 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
BRD-K04800985 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
BRD-K97651142 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.004 |
mRNA |
myricetin |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |